HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.

AuthorsThomas Moulding
JournalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease (Int J Tuberc Lung Dis) Vol. 12 Issue 9 Pg. 1102; author reply 1102 (Sep 2008) ISSN: 1027-3719 [Print] France
PMID18713512 (Publication Type: Comment, Letter)
Chemical References
  • Antitubercular Agents
  • Isoniazid
Topics
  • Antitubercular Agents (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Isoniazid (administration & dosage, therapeutic use)
  • Randomized Controlled Trials as Topic
  • Tuberculosis, Multidrug-Resistant (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: